Joseph Thomas Rabban III, MD, MPH
Research and Clinical Interests
My clinical field is diagnostic surgical pathology, specializing in pathologic diagnosis of women’s diseases and cancers (gynecologic pathology [diseases of the ovary, uterus, peritoneum, vagina, vulva] and breast pathology. As a member of the UCSF Multidisciplinary Gynecologic Tumor Board and the Multidisciplinary Breast Tumor Board, I work closely with surgeons and oncologists, providing pathologic consultation in both areas of women’s cancer. In addition, I am a member of the Cancer Risk Program, which is a multidisciplinary team dedicated to providing care for women with inherited cancers, such as those associated with BRCA mutations or Lynch syndrome.
My clinical research focuses on differential diagnostic criteria and tumor classification of women’s cancer (GYN and breast) as well as the pathology of inherited cancers, including BRCA and Lynch syndrome.
My teaching emphasis is gynecologic and breast pathology at continuing medical education at national, international, and regional courses. Within our training program, I serve as director of the Fellowship in General Surgical Pathology. I also teach medical students within the UCSF School of Medicine.
- Rabban JT, Mackey A, Powell CB, Crawford B, Zaloudek CJ, Chen LM. Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: Implications for intraoperative specimen evaluation. Gynecol Oncol. 2011 Jun 1;121(3):466-71
- Rabban JT, Krasik E, Chen LM, Powell CB, Crawford B, Zaloudek CJ. Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol. Am J Surg Pathol. 2009 Dec;33(12):1878-85.
- Rabban JT, Barnes M, Chen LM, Powell CB, Crawford B, Zaloudek CJ. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma. Am J Surg Pathol. 2009 Aug;33(8):1125-36.
- Rabban JT, Crawford B, Chen LM, Powell CB, Zaloudek CJ. Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations. Am J Surg Pathol. 2009 Jan;33(1):111-9.
- Rabban JT, Glidden D, Kwan ML, Chen YY. Pure and predominantly pure intralymphatic breast carcinoma after neoadjuvant chemotherapy: an unusual and adverse pattern of residual disease. Am J Surg Pathol. 2009 Feb;33(2):256-63.
- Rabban JT, Lerwill MF, McCluggage WG, Grenert JP, Zaloudek CJ. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary. Int J Gynecol Pathol. 2009 Jan;28(1):41-8.
- Rabban JT, Chen YY. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma. Hum Pathol. 2008 Feb;39(2):175-83.
- Associate Professor of Pathology
- Director, General Surgical Pathology Fellowship
- Director, Gynecologic Pathology Fellowship
- Anatomic Pathology
- Surgical Pathology
Gynecologic Pathology and Breast Pathology
- Phone: 415-353-2292
- Pager: 415-443-3805
- Fax: 415-353-1200
- UCSF Department of Anatomic Pathology
- 505 Parnassus Avenue
- Room M-552, Box 0102
- San Francisco, CA 94143
Other UCSF Organizational Association(s)
- UCSF Comprehensive Cancer Center
- Mt. Zion